Ownership and insider activity for Centene Corp. (CNC): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other.
Price
| Price | $68.45 (closing price, October 30, 2026) |
| Market Cap | $33.9B |
| Exchange | NYSE |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-10-15 | Carson Michael A | F-InKind | 7,130 | $500K |
| 2026-09-30 | Tyler Lauren M | A-Award | 482 | |
| 2026-09-30 | TANJI KENNETH | A-Award | 603 | |
| 2026-09-30 | Samuels Theodore R. II | A-Award | 583 | |
| 2026-09-30 | EPPINGER FREDERICK H | A-Award | 864 | |
| 2026-09-30 | COUGHLIN CHRISTOPHER J | A-Award | 583 | |
| 2026-09-15 | PIENKOS THEODORE J | F-InKind | 1,092 | $76K |
| 2026-08-26 | KOSTER CHRISTOPHER | S-Sale | 56,500 | $3.8M |
| 2026-08-18 | KOSTER CHRISTOPHER | S-Sale | 47,603 | $3.1M |
| 2026-07-28 | DIAZ PAUL J | A-Award | 2,771 |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.93B | $4.07B | $5.34B | $12.12B | $10.80B | $13.12B | $12.07B | $17.19B | $14.06B | $17.89B |
| Short-term Investments | $505.0M | $531.0M | $722.0M | $863.0M | $1.58B | $1.54B | $2.32B | $2.46B | $2.62B | 0 |
| Receivables | $3.21B | $3.41B | $5.15B | $6.25B | $9.70B | $12.24B | $13.27B | $15.53B | $19.71B | $18.11B |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | $8.37B | $8.70B | $12.00B | $20.32B | $23.39B | $28.50B | $30.13B | $40.76B | $38.00B | $35.99B |
| Property, Plant & Equipment | $797.0M | $1.10B | $1.71B | $2.78B | $2.77B | $6.96B | $4.99B | $2.42B | $2.43B | $2.35B |
| Goodwill | $4.71B | $4.75B | $7.01B | $6.86B | $18.65B | $19.77B | $18.81B | $17.56B | $17.56B | $10.84B |
| Intangible Assets | $1.54B | $1.40B | $2.24B | $2.06B | $8.39B | $7.82B | $6.91B | $6.10B | $5.41B | $4.53B |
| Total Assets | $20.20B | $21.86B | $30.90B | $40.99B | $68.72B | $78.38B | $76.87B | $84.64B | $82.44B | $77.66B |
| Accounts Payable | $3.76B | $4.17B | $4.05B | $4.00B | $7.07B | $8.29B | $9.35B | $16.25B | $13.02B | $20.54B |
| Short-term Debt | $4.0M | $4.0M | $38.0M | $88.0M | $97.0M | $267.0M | $82.0M | $119.0M | $110.0M | $196.0M |
| Total Current Liabilities | $8.62B | $9.33B | $11.97B | $12.93B | $21.59B | $25.77B | $28.46B | $36.72B | $34.26B | $21.48B |
| Long-term Debt | $4.65B | $4.70B | $6.65B | $13.64B | $16.68B | $18.57B | $17.94B | $17.71B | $18.42B | $17.97B |
| Total Liabilities | $14.14B | $14.98B | $19.88B | $28.30B | $42.76B | $51.35B | $52.63B | $58.69B | $55.94B | $57.60B |
| Retained Earnings | $1.92B | $2.75B | $3.66B | $4.98B | $6.79B | $8.14B | $9.34B | $12.04B | $15.35B | $8.67B |
| Total Equity | $5.89B | $6.85B | $10.92B | $12.55B | $25.77B | $26.80B | $24.06B | $25.84B | $26.41B | $19.95B |
| Total Debt | $4.66B | $4.70B | $6.69B | $14.51B | $18.32B | $22.66B | $21.33B | $18.88B | $19.43B | $18.78B |
| Net Debt | $220.0M | $96.0M | $622.0M | $1.52B | $5.94B | $8.00B | $6.94B | -$775.0M | $2.74B | $889.0M |
| Working Capital | -$258.0M | -$629.0M | $27.0M | $7.39B | $1.81B | $2.73B | $1.66B | $4.04B | $3.74B | $14.52B |
Financial Health
| Debt / Equity | 0.70 |
| Current Ratio | 1.16 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 2.78 |
Profitability
| Return on Equity | 6.78% |
| Return on Invested Capital | 2.24% |
| Return on Assets | 1.84% |
| Gross Margin | 16.41% |
| Operating Margin | 0.61% |
| Net Margin | 0.75% |
Related companies: UNH · CVS · CI · ELV · HUM · MOH · OSCR
Explore sector: Healthcare · Medical - Healthcare Plans
More sections of CNC: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks